Coya Therapeutics, Inc.
COYA
$5.26
$0.040.77%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 17.51% | 185.29% | 179.15% | 120.52% | 449.86% |
Total Receivables | -90.26% | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 389.73% | 375.12% | 157.25% | 32.91% | -14.52% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 7.55% | 200.33% | 177.19% | 115.40% | 473.37% |
|
|||||
Total Current Assets | 7.55% | 200.33% | 177.19% | 115.40% | 473.37% |
Net Property, Plant & Equipment | -41.43% | -37.64% | -34.30% | -31.68% | -29.37% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 7.48% | 198.87% | 176.02% | 114.67% | 391.48% |
|
|||||
Total Accounts Payable | 37.41% | -46.89% | 692.55% | 193.08% | -36.34% |
Total Accrued Expenses | -38.29% | 20.17% | 2.00% | 81.83% | 12.00% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -48.49% | -- | -- | -- | -- |
Total Other Current Liabilities | -48.49% | -- | -- | -- | -- |
Total Current Liabilities | -24.30% | 28.36% | 213.25% | 241.05% | 32.13% |
|
|||||
Total Current Liabilities | -24.30% | 28.36% | 213.25% | 241.05% | 32.13% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 64.50% | -- | -- | -- | -- |
Total Liabilities | -15.23% | 96.04% | 283.39% | 294.85% | -66.49% |
|
|||||
Common Stock & APIC | 30.59% | 87.66% | 86.90% | 72.62% | 8,926.01% |
Retained Earnings | -57.55% | -39.45% | -42.61% | -50.00% | -44.70% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 11.06% | 217.28% | 166.13% | 100.55% | 307.34% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 11.06% | 217.28% | 166.13% | 100.55% | 307.34% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 11.06% | 217.28% | 166.13% | 100.55% | 524.56% |
|